Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Celldex Therapeutics, Inc. | a2202475z10-k.htm |
| EX-32 - EX-32 - Celldex Therapeutics, Inc. | a2202475zex-32.htm |
| EX-21.0 - EX-21.0 - Celldex Therapeutics, Inc. | a2202475zex-21_0.htm |
| EX-31.1 - EX-31.1 - Celldex Therapeutics, Inc. | a2202475zex-31_1.htm |
| EX-31.2 - EX-31.2 - Celldex Therapeutics, Inc. | a2202475zex-31_2.htm |
| EX-10.53 - EXHIBIT 10.53 - Celldex Therapeutics, Inc. | a2202475zex-10_53.htm |
| EX-10.54 - EX10.54 - Celldex Therapeutics, Inc. | a2202475zex-10_54.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-151728, 333-117602 and 333-162423) and on Form S-3 (Nos. 333-143112, 333-162613 and 333-165899) of Celldex Therapeutics, Inc. of our report dated March 9, 2011 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston,
Massachusetts
March 9, 2011